Lev El Diagnostics Of Heart Diseases

About HeartTrends™: A medically proven, non-invasive analysis obtained from just 1 hour of cardiac data from a standard Holter device to detect myocardial ischemia related to Coronary Artery Disease (CAD) at its early stages. This CE-cleared, HIPAA-compliant, web-based test consists of an innovative multivariate analysis that culminates in a conclusive test score. The test is inexpensive, performed in a clinic or at home, with no need for technicians or physician to be present during the test. It is envisioned to be utilized as the initial risk-free diagnostic tool for individuals both sick and healthy without known CAD disease. HeartTrends is available commercially on a server-based business model (no software or hardware license charges) throughout the world and shortly within the U.S. pending FDA approval. About Lev El Ltd. Lev El Diagnostics of Heart Diseases Ltd. (Lev El) is a privately-held biomedical company committed to delivering innovative prognostic capabilities for accurate and reliable cardiovascular disease detection.